ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Sunday, 8 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Acquisition

Natco Pharma Acquisition Worth ₹133 Cr

NATCO Pharma Limited is investing US$ 14 million (approx. ₹133 Crore) in eGenesis, Inc. via convertible promissory notes. This increases NATCO's total investment in the biotechnology firm to US$ 22 million.

Key figures
Value₹133.0 Cr
Execution periodSeptember 30, 2026
Source

NSE filing, NSE: NATCOPHARM. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Natco Pharma Ltd: key numbers

Share price
₹807.00
Market cap
₹15,831 Cr
Revenue (annual)
₹4,078 Cr
Net profit (annual)
₹1,418 Cr
P/E (TTM)
13.8×Sector 43.0×
Promoter holding
46.22%-3.20% QoQ
FII holding
15.37%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Natco Pharma Ltd

All →

Other acquisition announcements

All →